Walleye Capital LLC - KARYOPHARM THERAPEUTICS INC ownership

KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Capital LLC ownership history of KARYOPHARM THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$220,563
-59.5%
56,700
-64.6%
0.00%
-70.0%
Q4 2022$545,044
-85.2%
160,307
-76.2%
0.01%
-85.7%
Q3 2022$3,678,000
-53.3%
673,672
-61.4%
0.07%
-67.7%
Q2 2022$7,872,000
+1186.3%
1,745,415
+2000.9%
0.22%
+1256.2%
Q1 2022$612,000
+587.6%
83,078
+497.6%
0.02%
+433.3%
Q4 2021$89,000
-84.1%
13,903
-52.3%
0.00%
-97.6%
Q1 2020$560,000
-60.5%
29,140
-60.6%
0.12%
+34.8%
Q4 2019$1,418,00073,9460.09%
Other shareholders
KARYOPHARM THERAPEUTICS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Consonance Capital Management LP 7,180,700$137,941,00010.27%
Palo Alto Investors LP 4,299,901$82,601,0006.92%
Fairmount Funds Management LLC 562,351$10,803,0006.55%
Avoro Capital Advisors LLC 7,000,000$134,470,0004.54%
Pinz Capital Management, LP 8,820$1,694,0004.44%
Birchview Capital, LP 148,000$2,843,0002.52%
Elk Creek Partners, LLC 699,951$13,446,0002.31%
Parkman Healthcare Partners LLC 215,802$4,146,0001.92%
EAM Global Investors LLC 136,402$2,620,0001.53%
SPHERA FUNDS MANAGEMENT LTD. 550,000$10,566,0001.32%
View complete list of KARYOPHARM THERAPEUTICS INC shareholders